Concepedia

Toru Ichinose

TI

Statistics

Publications

8

Citations

334

H-Index

8

Active since

2013

Affiliations

Nagoya University(Current)

Takara (Japan)

Aichi Cancer Center

Tanta University

Toru Ichinose is an author at Nagoya University specializing in oncology, oncolytic virus therapy, and medicine.

Publications per year

2013–2024

8

Publications

8

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

Yoshiki Hirooka, Hideki Kasuya, Takuya Ishikawa et al. · BMC Cancer · 2018 · 150 citations · Full text

, , +14

Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft

Gewen Tan, Hideki Kasuya, Tevfik Tolga Şahin et al. · International Journal of Cancer · 2014 · 59 citations · Full text

, , +14

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth

Zhiwen Wu, Toru Ichinose, Yoshinori Naoe et al. · Molecular Therapy — Oncolytics · 2019 · 29 citations · Full text

, , +17

Evaluation of antiviral activity of Oligonol, an extract of Litchi chinensis, against betanodavirus

Toru Ichinose · Drug Discoveries & Therapeutics · 2013 · 28 citations

, , +17

Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas

Nobuhiko Kanaya, Yohei Kitamura, María López Vázquez et al. · Science Translational Medicine · 2023 · 26 citations · Full text

, , +17

1–5 of 8